Coronavirus Update: AstraZeneca Makes Case For Vaxzevria Booster Against Omicron
As CEPI And SK Bio Look At 'Variant-Proof' Vaccines
Also, AstraZeneca presents more promising data for its COVID-19 antibody cocktail Evusheld and Novavax says its vaccine is able to neutralize the Omicron variant.
